Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Using MDEFT MRI Sequences to Target the GPi in DBS Surgery.

Nowacki A, Fiechter M, Fichtner J, Debove I, Lachenmayer L, Schüpbach M, Oertel MF, Wiest R, Pollo C.

PLoS One. 2015 Sep 14;10(9):e0137868. doi: 10.1371/journal.pone.0137868. eCollection 2015.

2.

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.

Gross RE, Watts RL, Hauser RA, Bakay RA, Reichmann H, von Kummer R, Ondo WG, Reissig E, Eisner W, Steiner-Schulze H, Siedentop H, Fichte K, Hong W, Cornfeldt M, Beebe K, Sandbrink R; Spheramine Investigational Group..

Lancet Neurol. 2011 Jun;10(6):509-19. doi: 10.1016/S1474-4422(11)70097-7. Epub 2011 May 10.

PMID:
21565557
3.

Prevalence and impact of pain in neurological inpatients of a German teaching hospital.

Gerbershagen K, Gerbershagen HU, Lindena GU, Lachenmayer L, Lefering R, Schmidt CO, Kohlmann T.

Clin Neurol Neurosurg. 2008 Jul;110(7):710-7. doi: 10.1016/j.clineuro.2008.04.011. Epub 2008 Jun 3.

PMID:
18524473
4.

Diffusion tensor pyramidal tractography in patients with anterior choroidal artery infarcts.

Nelles M, Gieseke J, Flacke S, Lachenmayer L, Schild HH, Urbach H.

AJNR Am J Neuroradiol. 2008 Mar;29(3):488-93. Epub 2007 Dec 13.

5.

NXY-059 for acute ischemic stroke.

Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM, Diener HC, Grotta J, Lyden P, Shuaib A, Hårdemark HG, Wasiewski WW; Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators..

N Engl J Med. 2006 Feb 9;354(6):588-600.

6.

Restless legs syndrome--new insights into clinical characteristics, pathophysiology, and treatment options.

Stiasny-Kolster K, Trenkwalder C, Fogel W, Greulich W, Hahne M, Lachenmayer L, Oechsner M, Oertel WH.

J Neurol. 2004 Sep;251 Suppl 6:VI/39-43. Review.

PMID:
15675724
7.

[Duplex ultrasound of external carotid artery branches for the detection of dural arteriovenous fistulae].

Arning C, Grzyska U, Lachenmayer L.

Rofo. 2005 Feb;177(2):236-41. German.

PMID:
15666232
8.

Serotonin neurotoxins--past and present.

Baumgarten HG, Lachenmayer L.

Neurotox Res. 2004;6(7-8):589-614. Review.

PMID:
15639791
9.

Clinical applications of MAO-inhibitors.

Riederer P, Lachenmayer L, Laux G.

Curr Med Chem. 2004 Aug;11(15):2033-43. Review.

PMID:
15279566
10.

[Factors influencing duration of hospitalization after stroke in Germany].

Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, Von Reutern GM, Lachenmayer L, Bücker-Nott HJ, Berger K.

Dtsch Med Wochenschr. 2004 Feb 13;129(7):299-304. German.

PMID:
14765327
11.

Selegiline's neuroprotective capacity revisited.

Riederer P, Lachenmayer L.

J Neural Transm (Vienna). 2003 Nov;110(11):1273-8. No abstract available.

PMID:
14628191
12.

[Quantifying stenosis of the internal carotid artery: which ultrasound criteria are relevant?].

Arning C, Hammer E, Kortmann H, Hahm H, Müller-Jensen A, Lachenmayer L.

Ultraschall Med. 2003 Aug;24(4):233-8. German.

PMID:
12939690
13.

Differential diagnosis of parkinsonian syndromes: dynamics of time courses are essential.

Lachenmayer L.

J Neurol. 2003 Feb;250 Suppl 1:I11-4. Review.

PMID:
12761629
14.

Which factors influence therapeutic decisions in Parkinson's disease?

Baas H, Fuchs G, Gemende I, Hueber R, Lachenmayer L, Schneider E, Schoenberger B, Werner M.

J Neurol. 2002 Oct;249 Suppl 3:III/49-52. Review.

PMID:
12522573
15.

Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.

Przuntek H, Bittkau S, Bliesath H, Büttner U, Fuchs G, Glass J, Haller H, Klockgether T, Kraus P, Lachenmayer L, Müller D, Müller T, Rathay B, Sgonina J, Steinijans V, Teshmar E, Ulm G, Volc D.

Arch Neurol. 2002 May;59(5):803-6.

PMID:
12020263
16.

Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.

Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Höppner W, Stavrou D, Fillbrandt R, Westphal M.

Int J Cancer. 2001 Mar 15;91(6):803-8.

17.

["Sleep attacks" in Parkinson patients].

Lachenmayer L.

Nervenarzt. 2001 Feb;72(2):160-1. German. No abstract available.

PMID:
11256153
18.

Workshop I: Parkinson's disease and sleep--results of the group discussion.

Clarenbach P, Greulich W, Meinck HM, Rathey B, Schipper H, Lachenmayer L, Werner M.

J Neurol. 2000 Sep;247 Suppl 4:IV/34-5. Review.

PMID:
11199816
19.

Parkinson's disease and the ability to drive.

Lachenmayer L.

J Neurol. 2000 Sep;247 Suppl 4:IV/28-30. Review.

PMID:
11199814
20.

[1st long-term double-blind study of effectiveness and dyskinesia prevention of ropinirol].

Reichmann H, Lachenmayer L.

Nervenarzt. 2000 Dec;71(12):1012-4. German.

PMID:
11139984

Supplemental Content

Loading ...
Support Center